MS Biotech Holdings
Littleton, US · Founded 2018 · Delaware corporation · 1 known investors
Founders & leadership
SS
Spencer SwayzeNamed on SEC filing
RS
Rich ShulerNamed on SEC filing
LV
Leander van der WaltNamed on SEC filing
SP
Steve PadgetteNamed on SEC filing
DM
Daniel MayNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$59.1M disclosed across 1 round · 2018
▶$59.1MraisedOct 2018 · 27 investors · AgricultureRule 506(b)
▶$59.1MraisedOct 2018 · 27 investors · Agriculture
Rule 506(b)Officers, directors & promoters on the filing
- Spencer SwayzeExecutive Officer, Director
- Rich ShulerDirector
- Leander van der WaltExecutive Officer, Director
- Steve PadgetteDirector
- Daniel MayDirector
- Offering amount
- $59.1M
- Amount sold
- $59.1M
- Finders' fees
- $1.5M
- Proceeds to insiders
- $603.5K
- Placement agents
- TJ Bender & Company, Inc.
- First sale
- Sep 2018
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are MS Biotech Holdings's investors?
- MS Biotech Holdings's investors include Paine Schwartz Partners.
- How much funding has MS Biotech Holdings raised?
- MS Biotech Holdings has disclosed $59.1M raised across 1 round.
- Where is MS Biotech Holdings headquartered?
- MS Biotech Holdings is headquartered in Littleton, US.